ARZERRA Is an Approved Anti-CD20 First-Line Therapy in CLL With Your Choice of Chlorambucil or Bendamustine1

View the PFS & TTNT data: ARZERRA + chlorambucil.

Reference: 1. Arzerra® (ofatumumab) summary of product characteristics. West Sussex, UK; Novartis Europharm Limited; 2016.